{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:40:18Z","timestamp":1771000818147,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s13312-020-1872-0","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T18:04:37Z","timestamp":1594145077000},"page":"588-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Demystifying BCG Vaccine and COVID-19 Relationship"],"prefix":"10.1007","volume":"57","author":[{"given":"Jogender","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitendra","family":"Meena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"1872_CR1","unstructured":"Ella KM, Mohan KV. Coronavirus vaccines: Light at the end of the tunnel. Indian Pediatr. 2020 Apr 15 [Epub] Available from: https:\/\/www.indianpediatrics.net\/COVID29.03.2020\/PERS-00163.pdf. Accessed April 26, 2020."},{"key":"1872_CR2","unstructured":"World Health Organization. Bacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19. Available from: https:\/\/www.who.int\/news-room\/commentaries\/detail\/bacille-calmette-guerin-(bcg)-vaccination-and-covid-19."},{"key":"1872_CR3","unstructured":"SAGE Working Group on BCG Vaccines and WHO Secretariat. Report on BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculous mycobacteria (NTM) infections. World Health Organization; 2017. Available from: https:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_BCG_report_revised_version_online.pdf. Accessed April 14, 2020."},{"key":"1872_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","volume":"25","author":"SJCFM Moorlag","year":"2019","unstructured":"Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect. 2019;25: 1473\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"1872_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang SY, Oosting M, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23:89\u2013100.e5.","journal-title":"Cell Host Microbe"},{"key":"1872_CR6","doi-asserted-by":"publisher","first-page":"e1912014","DOI":"10.1001\/jamanetworkopen.2019.12014","volume":"2","author":"NT Usher","year":"2019","unstructured":"Usher NT, Chang S, Howard RS, Martinez A, Harrison LH, Santosham M, et al. Association of BCG vaccination in childhood with subsequent cancer diagnoses: A 60-Year Follow-up of a clinical trial. JAMA Network Open. 2019;2: e1912014.","journal-title":"JAMA Network Open"},{"key":"1872_CR7","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1016\/j.vaccine.2019.06.056","volume":"37","author":"S Abbott","year":"2019","unstructured":"Abbott S, Christensen H, Lalor MK, Zenner D, Campbell C, Ramsay ME, et al. Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system. Vaccine. 2019;37: 5067\u201372.","journal-title":"Vaccine"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-020-1872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-020-1872-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-020-1872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T23:52:09Z","timestamp":1619740329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-020-1872-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1007\/s13312-020-1872-0","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"30 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}